Milan, Italy and Houston, TX, September 8, 2015 - Sorin S.p.A., (MTA; Reuters Code: SORN.MI, "Sorin"), a global medical device company and a leader in the treatment of cardiovascular diseases, and Cyberonics, Inc. (NASDAQ: CYBX, "Cyberonics"), a medical device company with core expertise in neuromodulation, today announced that no appeal of the decision of the Civil Court of Milan at first instance to refuse to enjoin the planned combination of Sorin and Cyberonics (the "Transaction") under a newly formed holding company, LivaNova PLC ("LivaNova") has been filed within the prescribed deadline.

Click here to view the release

distributed by